Second Cancers Among 104760 Survivors of Cervical Cancer: Evaluation of Long-Term Risk
Anil K. Chaturvedi(National Cancer Institute), Lois B. Travis(Indiana University – Purdue University Indianapolis), Ruth A. Kleinerman(National Cancer Institute), Eric A. Engels(National Cancer Institute), John D. Boice(Vanderbilt University), Per Hall(Karolinska Institutet), Hans H. Storm(Danish Cancer Society), Sophie D. Fosså(Oslo University Hospital), Eero Pukkala(Tampere University), Magnus Kaijser(Karolinska University Hospital), Charles F. Lynch(University of Iowa), Heikki Joensuu(Orion Corporation (Finland)), Michael Andersson(University of Copenhagen), Ethel S. Gilbert(National Institutes of Health), Frøydis Langmark(Norwegian Cancer Society), Bingshu E. Chen(University of Iowa)
Cited by 339
Related Papers
Efficacy and Safety of Imatinib Mesylate in Advanced Gastrointestinal Stromal Tumors
|New England Journal of Medicine|2002|4.4k
Environmental and Heritable Factors in the Causation of Cancer — Analyses of Cohorts of Twins from Sweden, Denmark, and Finland
|New England Journal of Medicine|2000|4.1k
Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States
|Journal of Clinical Oncology|2011|3.6k
Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2018|1.6k
Incidence Trends for Human Papillomavirus–Related and –Unrelated Oral Squamous Cell Carcinomas in the United States
|Journal of Clinical Oncology|2008|1.6k